BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15292302)

  • 1. Osteoprotegerin gene polymorphisms in men with coronary artery disease.
    Soufi M; Schoppet M; Sattler AM; Herzum M; Maisch B; Hofbauer LC; Schaefer JR
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3764-8. PubMed ID: 15292302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans.
    Rhee EJ; Oh KW; Jung CH; Lee WY; Oh ES; Yun EJ; Baek KH; Kang MI; Kim SW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):689-97. PubMed ID: 16712673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased osteoprotegerin serum levels in men with coronary artery disease.
    Schoppet M; Sattler AM; Schaefer JR; Herzum M; Maisch B; Hofbauer LC
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1024-8. PubMed ID: 12629080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
    Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
    Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures.
    Langdahl BL; Carstens M; Stenkjaer L; Eriksen EF
    J Bone Miner Res; 2002 Jul; 17(7):1245-55. PubMed ID: 12096838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis.
    Arko B; Prezelj J; Komel R; Kocijancic A; Hudler P; Marc J
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4080-4. PubMed ID: 12213850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymorphisms of T149C and T950C genes in osteoprotegerin promoter sites and the relationship between serum osteoprotegerin levels and coronary heart disease].
    Zhao F; Zhao H; Zhang R; Ren M; Liu C; Liu S; Ma J; Song Y; Liu T; Zhang X; Cong H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Mar; 31(3):319-324. PubMed ID: 30914093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density.
    Celczyńska Bajew L; Horst Sikorska W; Bychowiec B; Wykrętowicz A; Wesoły J; Michalak M
    Kardiol Pol; 2011; 69(6):573-8. PubMed ID: 21678294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?
    Masi L; Simonini G; Piscitelli E; Del Monte F; Giani T; Cimaz R; Vierucci S; Brandi ML; Falcini F
    J Rheumatol; 2004 May; 31(5):986-91. PubMed ID: 15124262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women.
    Brändström H; Gerdhem P; Stiger F; Obrant KJ; Melhus H; Ljunggren O; Kindmark A; Akesson K
    Calcif Tissue Int; 2004 Jan; 74(1):18-24. PubMed ID: 14508625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction.
    Crisafulli A; Micari A; Altavilla D; Saporito F; Sardella A; Passaniti M; Raffa S; D'anneo G; Lucà F; Mioni C; Arrigo F; Squadrito F
    Clin Sci (Lond); 2005 Oct; 109(4):389-95. PubMed ID: 15926884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function.
    Brändström H; Stiger F; Lind L; Kahan T; Melhus H; Kindmark A
    Biochem Biophys Res Commun; 2002 Apr; 293(1):13-7. PubMed ID: 12054556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease.
    Jono S; Ikari Y; Shioi A; Mori K; Miki T; Hara K; Nishizawa Y
    Circulation; 2002 Sep; 106(10):1192-4. PubMed ID: 12208791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis.
    Ohmori H; Makita Y; Funamizu M; Hirooka K; Hosoi T; Orimo H; Suzuki T; Ikari K; Nakajima T; Inoue I; Hata A
    J Hum Genet; 2002; 47(8):400-6. PubMed ID: 12181640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of C161-->T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-gamma gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women.
    Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
    Am J Obstet Gynecol; 2005 Apr; 192(4):1087-93. PubMed ID: 15846185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios.
    Jørgensen HL; Kusk P; Madsen B; Fenger M; Lauritzen JB
    J Bone Miner Metab; 2004; 22(2):132-8. PubMed ID: 14999524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.
    Magal I; Lebel E; Altarescu G; Itzchaki M; Rudensky B; Foldes AJ; Zimran A; Elstein D
    Br J Haematol; 2006 Apr; 133(1):93-7. PubMed ID: 16512834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.
    Hofbauer LC; Shui C; Riggs BL; Dunstan CR; Spelsberg TC; O'Brien T; Khosla S
    Biochem Biophys Res Commun; 2001 Jan; 280(1):334-9. PubMed ID: 11162519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.